Financials Orthocell Limited

Equities

OCC

AU000000OCC6

Advanced Medical Equipment & Technology

Delayed Australian S.E. 23:26:36 2024-06-25 EDT 5-day change 1st Jan Change
0.365 AUD +1.39% Intraday chart for Orthocell Limited -2.67% -10.98%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 35.26 78.22 58.18 112.4 79.84 69.06
Enterprise Value (EV) 1 32.35 66.98 38.24 96.74 69.32 44.8
P/E ratio -5.82 x -10.3 x -8.75 x -12.2 x -8.62 x -10.9 x
Yield - - - - - -
Capitalization / Revenue 56.9 x 82.7 x 80.9 x 110 x 52.1 x 16.3 x
EV / Revenue 52.2 x 70.8 x 53.1 x 95 x 45.3 x 10.6 x
EV / EBITDA -4.13 x -8.07 x -4.29 x -8.56 x -6.14 x -4.51 x
EV / FCF -7.72 x -18.2 x -7.73 x -31.9 x -2.72 x 2.83 x
FCF Yield -13% -5.49% -12.9% -3.14% -36.8% 35.3%
Price to Book 14.9 x 7.29 x 2.78 x 6.66 x 8.06 x 11.2 x
Nbr of stocks (in thousands) 110,178 153,367 184,699 190,584 197,128 197,303
Reference price 2 0.3200 0.5100 0.3150 0.5900 0.4050 0.3500
Announcement Date 18-08-31 19-08-30 20-08-31 21-08-27 22-08-30 23-08-31
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 0.6192 0.9457 0.7195 1.018 1.532 4.243
EBITDA 1 -7.839 -8.298 -8.911 -11.3 -11.3 -9.925
EBIT 1 -8.032 -8.516 -9.172 -11.63 -11.52 -10.28
Operating Margin -1,297.18% -900.57% -1,274.73% -1,142.59% -752.21% -242.28%
Earnings before Tax (EBT) 1 -8.009 -8.38 -9.056 -11.43 -11.25 -9.411
Net income 1 -5.757 -5.852 -6.151 -9.037 -9.107 -6.248
Net margin -929.8% -618.85% -854.88% -887.76% -594.53% -147.26%
EPS 2 -0.0550 -0.0494 -0.0360 -0.0484 -0.0470 -0.0320
Free Cash Flow 1 -4.192 -3.676 -4.945 -3.037 -25.51 15.84
FCF margin -676.99% -388.71% -687.19% -298.32% -1,665.27% 373.22%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-08-31 19-08-30 20-08-31 21-08-27 22-08-30 23-08-31
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 2.91 11.2 19.9 15.7 10.5 24.3
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -4.19 -3.68 -4.94 -3.04 -25.5 15.8
ROE (net income / shareholders' equity) -163% -89.4% -38.9% -47.8% -68% -77.8%
ROA (Net income/ Total Assets) -81% -56.5% -31.2% -34.2% -25.2% -19%
Assets 1 7.104 10.35 19.73 26.42 36.18 32.82
Book Value Per Share 2 0.0200 0.0700 0.1100 0.0900 0.0500 0.0300
Cash Flow per Share 2 0.0300 0.0700 0.1100 0.0900 0.0600 0.1300
Capex 1 0.09 0.01 0.01 0.15 0.52 0.61
Capex / Sales 14.08% 1.5% 1.01% 15.02% 33.77% 14.46%
Announcement Date 18-08-31 19-08-30 20-08-31 21-08-27 22-08-30 23-08-31
1AUD in Million2AUD
Estimates
  1. Stock Market
  2. Equities
  3. OCC Stock
  4. Financials Orthocell Limited